What is he best known for?
The fields of study he is best known for:
Philip S. Low mostly deals with Biochemistry, Folate receptor, Endocytosis, Cancer and Cancer research.
His Biochemistry study frequently intersects with other fields, such as Biophysics.
The Folate receptor study combines topics in areas such as Liposome, Immunology and In vivo.
Philip S. Low combines subjects such as Internalization, Cytoplasm, Cell biology and Folate-binding protein with his study of Endocytosis.
Philip S. Low focuses mostly in the field of Cancer, narrowing it down to topics relating to Endometrium and, in certain cases, Tumor marker and Lung.
His work in Cancer research covers topics such as Receptor which are related to areas like Pharmacology and Clinical trial.
His most cited work include:
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results (1092 citations)
- Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay (861 citations)
- Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay (861 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Biochemistry, Folate receptor, Band 3, Cancer research and Biophysics.
His work on Cell culture expands to the thematically related Biochemistry.
His Folate receptor research incorporates elements of Receptor, In vivo and Pathology.
His Band 3 study combines topics in areas such as Ankyrin, Spectrin and Cell biology.
His research integrates issues of Chimeric antigen receptor and Immunology, Antigen in his study of Cancer research.
His studies deal with areas such as Cytoplasm and Intracellular as well as Biophysics.
He most often published in these fields:
- Biochemistry (32.11%)
- Folate receptor (25.29%)
- Band 3 (16.81%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (15.31%)
- Folate receptor (25.29%)
- Receptor (9.82%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Folate receptor, Receptor, In vivo and Pathology.
His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Chimeric antigen receptor and Small molecule.
His Cancer research is multidisciplinary, incorporating elements of Moiety and Surgery.
Folate Receptor Alpha is the focus of his Folate receptor research.
As part of one scientific family, Philip S. Low deals mainly with the area of Receptor, narrowing it down to issues related to the Cell biology, and often Endocytosis, Nigericin and Cell.
The concepts of his In vivo study are interwoven with issues in Molecular biology, In vitro and Fluorescence.
Between 2017 and 2021, his most popular works were:
- Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters. (36 citations)
- Use of a Single CAR T Cell and Several Bispecific Adapters Facilitates Eradication of Multiple Antigenically Different Solid Tumors. (32 citations)
- Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer (26 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Folate receptor, Cancer research, Cancer cell, Receptor and In vivo.
Philip S. Low studies Folate receptor, focusing on Folate Receptor Alpha in particular.
The study incorporates disciplines such as Colitis, Folate receptor beta, Toxicity and Fibrosis, Pulmonary fibrosis in addition to Cancer research.
His research integrates issues of T cell and Chimeric antigen receptor in his study of Cancer cell.
Philip S. Low usually deals with In vivo and limits it to topics linked to In vitro and Cell culture, Cancer, Fluorescence, Downregulation and upregulation and Targeted drug delivery.
His Cell culture research incorporates elements of Biochemistry, Small molecule, Near-infrared spectroscopy and Acetazolamide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
